drugset
drugset / Trial / NCT05102903

A Clinical Trial to Compare the Pharmacokinetics and Safety of "BR1016A" With "BR1016B" in Healthy Volunteers

NCT05102903 ↗

Phase 1 Completed 60 enrolled Boryung Pharmaceutical Co., Ltd
RandomizedCrossoverOpen-labelTreatment

Summary

To evaluate the pharmacokinetic properties and safety of "BR1016A" and "BR1016B" in healthy adults.

Timeline

Start
2021-10-22
Primary completion
2021-12-14
Completion
2021-12-14

Drugs

EvaluationDrugModalityDoseRoute
Subject BR1016A Unknown — Oral
Subject BR1016B Unknown — Oral

Indications

heart failure